Drawing for OMNILOC

USPTO serial 75464115

OMNILOC

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
LEIPZIG, MARC J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OMNILOC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

PHILIP S LYREN

PHILIP S LYREN SULZER MEDICA USA INC3 E GREENWAY PLZ STE 1600HOUSTON, TX 77046UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010dental implantsACTIVEJul 10, 1990

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 30, 1999ABN1ABANDONMENT - EXPRESS MAILED—
Aug 19, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 21, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 16, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance